Cargando…
Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694096/ https://www.ncbi.nlm.nih.gov/pubmed/34956936 http://dx.doi.org/10.3389/fcimb.2021.813442 |
| _version_ | 1784619276552896512 |
|---|---|
| author | Thom, Ruth E. Eastaugh, Lin S. O’Brien, Lyn M. Ulaeto, David O. Findlay, James S. Smither, Sophie J. Phelps, Amanda L. Stapleton, Helen L. Hamblin, Karleigh A. Weller, Simon A. |
| author_facet | Thom, Ruth E. Eastaugh, Lin S. O’Brien, Lyn M. Ulaeto, David O. Findlay, James S. Smither, Sophie J. Phelps, Amanda L. Stapleton, Helen L. Hamblin, Karleigh A. Weller, Simon A. |
| author_sort | Thom, Ruth E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8694096 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86940962021-12-23 Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms Thom, Ruth E. Eastaugh, Lin S. O’Brien, Lyn M. Ulaeto, David O. Findlay, James S. Smither, Sophie J. Phelps, Amanda L. Stapleton, Helen L. Hamblin, Karleigh A. Weller, Simon A. Front Cell Infect Microbiol Cellular and Infection Microbiology Frontiers Media S.A. 2021-12-08 /pmc/articles/PMC8694096/ /pubmed/34956936 http://dx.doi.org/10.3389/fcimb.2021.813442 Text en Copyright © 2021 Thom, Eastaugh, O’Brien, Ulaeto, Findlay, Smither, Phelps, Stapleton, Hamblin and Weller https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cellular and Infection Microbiology Thom, Ruth E. Eastaugh, Lin S. O’Brien, Lyn M. Ulaeto, David O. Findlay, James S. Smither, Sophie J. Phelps, Amanda L. Stapleton, Helen L. Hamblin, Karleigh A. Weller, Simon A. Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title | Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title_full | Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title_fullStr | Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title_full_unstemmed | Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title_short | Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms |
| title_sort | corrigendum: evaluation of the sars-cov-2 inactivation efficacy associated with buffers from three kits used on high-throughput rna extraction platforms |
| topic | Cellular and Infection Microbiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694096/ https://www.ncbi.nlm.nih.gov/pubmed/34956936 http://dx.doi.org/10.3389/fcimb.2021.813442 |
| work_keys_str_mv | AT thomruthe corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT eastaughlins corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT obrienlynm corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT ulaetodavido corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT findlayjamess corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT smithersophiej corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT phelpsamandal corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT stapletonhelenl corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT hamblinkarleigha corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms AT wellersimona corrigendumevaluationofthesarscov2inactivationefficacyassociatedwithbuffersfromthreekitsusedonhighthroughputrnaextractionplatforms |